Skip to main content

stock

ATYR · aTYR PHARMA INC

What aTYR PHARMA INC reports to the SEC, read from its filings.

Open in the app

Price

The live ATYR price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ATYR.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
98,087,425 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-124.6%
ROA
-87.1%

Health

Current ratio
5.1x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$10.88M-$10.31M
10-Q filed 2026-08-07
2026-03-31——Gross profit: unreported by this company.-$11.44M-$10.79M
10-Q filed 2026-05-15
2025-12-31$0—Gross profit: unreported by this company.-$14.80M-$13.96M
10-K filed 2026-03-05
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$190,000—Gross profit: unreported by this company.-$26.75M-$25.74M
10-Q filed 2025-11-06
2025-06-30$0—Gross profit: unreported by this company.-$20.31M-$19.53M
10-Q filed 2026-08-07
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$0—Gross profit: unreported by this company.-$15.77M-$14.88M
10-Q filed 2026-05-15
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0—Gross profit: unreported by this company.-$15.82M-$14.97M
10-K filed 2026-03-05
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$0—Gross profit: unreported by this company.-$18.14M-$17.26M
10-Q filed 2025-11-06
Assets
$69.83M
Equity
$48.79M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$190,000-$77.63M-$74.12M-$62.06M
2024-12-31$235,000-$67.91M-$64.02M-$69.18M
2023-12-31$353,000-$54.92M-$50.39M-$37.44M
2022-12-31$10.39M-$46.40M-$45.34M-$43.53M
2021-12-31$0-$34.02M-$33.77M-$33.27M
2020-12-31$10.46M-$15.91M-$16.22M-$15.50M
2019-12-31$422,000-$22.98M-$16.22M-$20.09M
2018-12-31—-$32.82M-$34.52M-$31.66M
2017-12-31—-$47.15M-$48.21M-$43.68M
2016-12-31—-$57.94M-$57.85M-$53.46M

Company filings

events

  • Other event

    Other event
    Sep 248-K
  • Results

    Results
    Aug 78-K
  • Agreement ended

    Agreement ended
    Jul 318-K
  • Listing standard notice

    Listing standard notice
    Jun 88-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Jun 18-K
  • Results

    Results
    May 158-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named ATYR, and the market events around them.

Sign in to see this

Board

The ATYR board could not be loaded.

Retry the ATYR board

nakagai

Signals on ATYR come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ATYR board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

aTYR PHARMA INC (ATYR): SEC filings, financials and insider trades · Nakagai